MPM Files for IPO
Global chemicals manufacturer MPM has filed with the SEC regarding an initial public offering.
All Work
Chris Lange
Kroger Q2 Earnings Not Enough to Impress Investors
Kroger released quarterly results that were essentially in line with expectations and offered guidance early Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a mixed day for the U.S. broad markets with all major indices starting off positive, but quickly souring with the exception of the Nasdaq. Crude oil backed off after posting a few…
Why Kroger Earnings Can Stand Up to Amazon’s Onslaught
Grocery stores, among other industries, have been under attack by the unending onslaught of Amazon, especially after the Whole Foods acquisition.
How Bristol-Myers Actually Won by Stopping a Clinical Study
Usually when a clinical study is stopped it spells disaster for the company performing the study, but in this case Bristol-Myers Squibb is bucking that trend and investors are thrilled.
Celgene Faces Multiple Clinical Holds From FDA
Celgene received an update from the FDA early on Thursday. Although shares did not dip initially, this action could prove to be problematic for the biotech giant going forward.
Best Prices IPO Over $1 Billion
Best intends to price more than 62 million American depositary shares in the range of $13 to $15 apiece for an initial public offering valued up to about $1 billion.
Can GoPro Maintain a Profitable Turnaround?
GoPro saw its shares make a handy gain early on Thursday after the firm commented on its guidance for the third quarter.
How Apple Plans to Return $300 Billion to Shareholders
In an effort to further fund its capital return program, among other things, Apple has announced that it is issuing a debt offering.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a very positive day for the U.S. broad markets almost making up for the incredible loss that we saw on Tuesday. Crude oil continued its run to the $50 price level, and…
Why Verastem Is Knocking It Out of the Park
Verastem saw perhaps the biggest gain in the market Wednesday after the company announced positive late-stage results.
Can Gap’s New Long-Term Strategy Pay Off?
What’s pushing Gap stock higher is a new long-term plan that the executive management team has put together. Investors seem pretty thrilled about this plan, but will it succeed?
Trivago Tanks Following Updated Guidance
Trivago watched its shares get crushed on Wednesday after the company updated its full-year guidance.
Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial
Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.
Rhythm Pharmaceuticals Files for IPO
Biopharmaceutical company Rhythm Pharmaceuticals has with the SEC regarding its initial public offering.
How Insmed Is Capitalizing on Its Huge Late-Stage Success
Insmed has filed with the SEC for a secondary offering. This follows a surge in the share price following positive late-stage results from its clinical study in the treatment of nontuberculous mycobacteria lung disease.
Hewlett Packard Enterprise Clears Low Bar for Q3
Hewlett Packard Enterprise Co. (NYSE: HPE) released its fiscal third-quarter financial results after the markets closed on Tuesday. The company said that it had $0.30 in earnings per share (EPS) and $8.2 billion in…
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a down day for the U.S. broad markets, actually one of the worst trading days of the year. Despite this, crude oil managed to have one of its best days but not…
Why Merrill Lynch Is Growing Much More Bullish on US Steel Stocks
Rising input costs and a more bullish stance on China have created a bullish sentiment in steel stocks recently. One analyst has rasied its price targets on U.S. steel companies across the board.
Tilman Fertitta Buys Houston Rockets in Blockbuster Deal
After being on the market for nearly two months, the Houston Rockets have found a buyer for the franchise who will pay an unprecedented $2.2 billion.